X
New data sets up potential new gastro use for J&J’s Stelara
https://pharmaphorum.com/news/new-data-sets-up-potential-new-gastro-use-for-jjs-stelara/
ulcerative colitis
FDA approves oral treatment for ulcerative colitis
Pfizer’s janus kinase (JAK) inhibitor drug Xeljanz (tofacitinib) has received expanded approval from the FDA for adults with moderately-to-severely-active ulcerative colitis.
AZ sells potential Crohn’s drug to Allergan
Amgen gets share of $1.5 billion deal
Shire buys rights to Pfizer gastrointestinal drug
Shire has bought rights to PF-00547659 for an undisclosed sum.
